688331 荣昌生物
已收盘 09-30 15:00:01
资讯
新帖
简况
荣昌生物(09995)上涨9.96%,报17.0元/股
金融界 · 09-30 09:37
荣昌生物(09995)上涨9.96%,报17.0元/股
荣昌生物创2个月新高 获主力净流入1123万元
智选洞察 · 09-30 09:30
荣昌生物创2个月新高 获主力净流入1123万元
荣昌生物(688331)9月27日主力资金净买入188.76万元
证券之星 · 09-30 08:10
荣昌生物(688331)9月27日主力资金净买入188.76万元
港股生物技术股持续大涨,药明康德(02359.HK)涨近21%,荣昌生物(09995.HK)涨超20%,宜明昂科(01541.
美港电讯 · 09-27
港股生物技术股持续大涨,药明康德(02359.HK)涨近21%,荣昌生物(09995.HK)涨超20%,宜明昂科(01541.
港股生物医药股持续拉升,荣昌生物(09995.HK)涨超17%,药明康德(02359.HK)涨超11%,金斯瑞生物(01548.
美港电讯 · 09-27
港股生物医药股持续拉升,荣昌生物(09995.HK)涨超17%,药明康德(02359.HK)涨超11%,金斯瑞生物(01548.
南向资金9月25日净卖出荣昌生物59.70万股 连续3日减持
市场透视 · 09-26
南向资金9月25日净卖出荣昌生物59.70万股 连续3日减持
荣昌生物大幅上涨 生物医药行业创新发展
智选洞察 · 09-24
荣昌生物大幅上涨 生物医药行业创新发展
荣昌生物(688331)9月23日主力资金净买入32.39万元
证券之星 · 09-24
荣昌生物(688331)9月23日主力资金净买入32.39万元
荣昌生物(09995)上涨5.22%,报11.28元/股
金融界 · 09-23
荣昌生物(09995)上涨5.22%,报11.28元/股
荣昌生物几乎烧光IPO融资 累计亏逾30亿
新浪财经 · 09-23
荣昌生物几乎烧光IPO融资 累计亏逾30亿
9月20日荣昌生物跌5.90%,易方达医疗保健行业混合A基金重仓该股
证券之星 · 09-20
9月20日荣昌生物跌5.90%,易方达医疗保健行业混合A基金重仓该股
港股异动 | 荣昌生物(09995)跌超5% 被传裁员上千人 公司指人员调整旨在优化经营团队结构
智通财经 · 09-20
港股异动 | 荣昌生物(09995)跌超5% 被传裁员上千人 公司指人员调整旨在优化经营团队结构
荣昌生物(09995)下跌5.05%,报10.9元/股
金融界 · 09-20
荣昌生物(09995)下跌5.05%,报10.9元/股
【港股通】荣昌生物(09995)跌超4.5% 据报回应裁员传闻:近期人员调整非大幅裁员
金吾财讯 · 09-20
【港股通】荣昌生物(09995)跌超4.5% 据报回应裁员传闻:近期人员调整非大幅裁员
A股创新药概念震荡走低,海南海药跌超7%,睿智医药跌超5%;百奥泰、荣昌生物、恒瑞医药、广生堂等跟跌。
美港电讯 · 09-20
A股创新药概念震荡走低,海南海药跌超7%,睿智医药跌超5%;百奥泰、荣昌生物、恒瑞医药、广生堂等跟跌。
荣昌生物称近期人员调整非大幅裁员 旨在优化经营团队结构
北京商报 · 09-19
荣昌生物称近期人员调整非大幅裁员 旨在优化经营团队结构
荣昌生物(09995.HK):近期人员调整非大幅裁员 旨在优化经营团队结构
阿斯达克财经 · 09-19
荣昌生物(09995.HK):近期人员调整非大幅裁员 旨在优化经营团队结构
荣昌生物:近期人员调整非大幅裁员 系“实现团队的动态平衡”
美港电讯 · 09-19
荣昌生物:近期人员调整非大幅裁员 系“实现团队的动态平衡”
荣昌生物(688331)9月18日主力资金净卖出1091.41万元
证券之星 · 09-19
荣昌生物(688331)9月18日主力资金净卖出1091.41万元
荣昌生物大跌5.02% 3家券商给予增持建议
智选洞察 · 09-18
荣昌生物大跌5.02% 3家券商给予增持建议
暂无数据
公司概况
公司名称:
荣昌生物制药(烟台)股份有限公司
所属行业:
医药制造业
上市日期:
2022-03-31
主营业务:
荣昌生物制药(烟台)股份有限公司是一家具有全球化视野的创新型生物制药企业,自成立以来一直专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。公司主营业务是发现、开发与商业化创新、有特色的同类首创(first-in-class)与同类最佳(best-in-class)生物药,以创造药物临床价值为导向,为自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域提供安全、有效、可及的临床解决方案,以满足大量尚未被满足的临床需求。公司的核心产品为泰它西普、维迪西妥单抗、RC28。
发行价格:
48.00
{"stockData":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":35.11,"timestamp":1727679601000,"preClose":30.43,"halted":0,"volume":8309038,"delay":0,"floatShares":162000000,"shares":544000000,"eps":-2.918,"marketStatus":"已收盘","marketStatusCode":5,"change":4.68,"latestTime":"09-30 15:00:01","open":34,"high":35.35,"low":31.19,"amount":276000000,"amplitude":0.1367,"askPrice":35.11,"askSize":103,"bidPrice":35.01,"bidSize":12,"shortable":0,"etf":0,"ttmEps":-2.918,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1728351000000},"adr":0,"adjPreClose":30.43,"symbolType":"stock_kcb","openAndCloseTimeList":[[1727659800000,1727667000000],[1727672400000,1727679600000]],"highLimit":33.47,"lowLimit":27.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":544332083,"pbRate":7.17,"roa":"--","roe":"--","epsLYR":-2.8,"committee":-0.497537,"marketValue":19111000000,"floatMarketCap":5686000000,"peRate":-12.032214,"changeRate":0.1538,"turnoverRate":0.0513,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-10-08。","afterMarket":{"amount":105330,"volume":3000,"close":35.11,"buyVolume":219,"sellVolume":0,"time":1727681637153,"indexStatus":"已收盘 09-30 15:30:00","preClose":30.43}},"requestUrl":"/m/hq/s/688331/tweets","defaultTab":"tweets","newsList":[{"id":"2471598815","title":"荣昌生物(09995)上涨9.96%,报17.0元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471598815","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471598815?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:37","pubTimestamp":1727660275,"startTime":"0","endTime":"0","summary":"9月30日,荣昌生物(09995)盘中上涨9.96%,截至09:37,报17.0元/股,成交1517.74万元。荣昌生物制药(烟台)股份有限公司的主营业务是发现、开发、生产和商业化同类首创、同类最佳的生物药物,主要针对自身免疫、肿瘤、眼科等重大疾病领域。公司在中国和美国设有实验研究机构和办事处,已创制出一批具有重大临床价值的生物新药。截至2024年中报,荣昌生物营业总收入7.4亿元、净利润-7.8亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/30093743633010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688331","09995","BK1583","BK1161","BK1574","LU1064131003.USD","LU1969619763.USD","LU1064130708.USD","LU2148510915.USD","BK0239","LU2328871848.SGD"],"gpt_icon":0},{"id":"2471166668","title":"荣昌生物创2个月新高 获主力净流入1123万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471166668","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471166668?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:30","pubTimestamp":1727659802,"startTime":"0","endTime":"0","summary":"09月30日,荣昌生物股价大幅上涨,截至09点30分,荣昌生物上涨13.97%,报34.68元/股,创近2个月新高,成交383万元,换手率0.07%,振幅2.23%。资金动向截止发稿,荣昌生物获得主力净流入1123万元,其中超大单流入1288万元,大单流出165万元。数据显示,该股今日净流入较近5日净流入均值增加1263万元。最新财报显示,今年中报,荣昌生物实现营业收入7.42亿元,同比增长75.59%,净利润为-7.80亿元,同比减少10.96%,基本每股收益为-1.45元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930095755ab66ee3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930095755ab66ee3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064131003.USD","BK0239","LU1064130708.USD","LU2148510915.USD","688331"],"gpt_icon":0},{"id":"2471891717","title":"荣昌生物(688331)9月27日主力资金净买入188.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471891717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471891717?lang=zh_cn&edition=full","pubTime":"2024-09-30 08:10","pubTimestamp":1727655051,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月27日收盘,荣昌生物报收于30.43元,上涨16.77%,换手率2.85%,成交量4.61万手,成交额1.34亿元。近5日资金流向一览见下表:荣昌生物融资融券信息显示,融资方面,当日融资买入468.85万元,融资偿还1058.53万元,融资净偿还589.68万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000005081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688331","BK1161","09995","BK1583","LU1969619763.USD","LU2148510915.USD","BK1574","LU1064131003.USD","BK0239","LU2328871848.SGD","LU1064130708.USD"],"gpt_icon":0},{"id":"2470973749","title":"港股生物技术股持续大涨,药明康德(02359.HK)涨近21%,荣昌生物(09995.HK)涨超20%,宜明昂科(01541.","url":"https://stock-news.laohu8.com/highlight/detail?id=2470973749","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470973749?lang=zh_cn&edition=full","pubTime":"2024-09-27 11:45","pubTimestamp":1727408741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603259","BK1141","LU0819121731.USD","LU1242518857.USD","LU2125910500.SGD","02359","07226","HK0000306701.USD","01541","LU0516423091.SGD","LU0516423174.USD","06127","LU2045819591.USD","09995","LU1880383366.USD","LU0516422366.SGD","LU2242644610.SGD","HK0000306685.HKD","LU1794554557.SGD","LU0708995583.HKD","LU0456827905.SGD","LU0516422952.EUR","LU2488822045.USD","LU0359202008.SGD","LU1064130708.USD","HSCEI","LU0320764599.SGD","LU0456842615.SGD","688331","LU0181495838.USD","LU2148510915.USD","LU0456846285.SGD","LU0588546209.SGD","BK1574","LU1242518931.SGD","BK1576","LU0140636845.USD","LU0326950275.SGD","YANG","LU0327786744.USD","01548","BK1583","BK1610","LU0307460666.USD","LU1046422090.SGD","LU1969619763.USD","LU0039217434.USD","603127","02269","HSTECH"],"gpt_icon":0},{"id":"2470175487","title":"港股生物医药股持续拉升,荣昌生物(09995.HK)涨超17%,药明康德(02359.HK)涨超11%,金斯瑞生物(01548.","url":"https://stock-news.laohu8.com/highlight/detail?id=2470175487","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470175487?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:13","pubTimestamp":1727403193,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","HK0000320264.USD","161726","LU0052750758.USD","HSTECH","LU1064131003.USD","09688","LU0043850808.USD","LU0572944931.SGD","YANG","BK1161","02359","BK0239","603259","LU0051755006.USD","LU0326950275.SGD","LU0348735423.USD","01548","LU0359201612.USD","LU1997245094.SGD","BK4531","399441","LU0856984785.SGD","BK1589","BK4548","LU0823426480.USD","LU2328871848.SGD","SG9999002463.SGD","BK0216","LU0823426308.USD","LU1720050803.USD","09995","07226","LU0417516738.SGD","BK1588","HSCEI","LU1997245177.USD","BK1521","LU0417516902.SGD","LU0348825331.USD","SG9999002562.SGD","HK0000320223.HKD","LU2039709279.SGD","LU0516422440.USD","02269","LU1688375341.USD","688331","ZLAB","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"2470242496","title":"南向资金9月25日净卖出荣昌生物59.70万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2470242496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470242496?lang=zh_cn&edition=full","pubTime":"2024-09-26 09:30","pubTimestamp":1727314218,"startTime":"0","endTime":"0","summary":"9月25日,南向资金减持荣昌生物59.70万股连续3日减持。截止当日收盘,港股通共持有荣昌生物7027.79万股,占流通股37.06%。荣昌生物近5个交易日上涨2.57%,港股通累计减持106.70万股;近20个交易日下跌3.39%,港股通累计减持98.15万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926093444957e0ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926093444957e0ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1583","LU2328871848.SGD","BK1574","688331","09995","BK1161"],"gpt_icon":0},{"id":"2469102098","title":"荣昌生物大幅上涨 生物医药行业创新发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2469102098","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469102098?lang=zh_cn&edition=full","pubTime":"2024-09-24 09:37","pubTimestamp":1727141836,"startTime":"0","endTime":"0","summary":"消息解读2024年上半年生物医药行业上市公司的半年报显示,创新和“出海”是行业发展的方向。2024年上半年,处于产业转型期的生物医药行业展现出多个亮点,重点表现在创新药收入占比持续增大、多家公司新药出海授权金额不断创新高等方面。生物医药行业正逐步向创新驱动转型,新药研发、出海授权、医疗设备创新等成为行业发展的新趋势。多家生物医药企业在半年报中披露了创新药研发的重要进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924093846a1dc0abc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924093846a1dc0abc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064130708.USD","LU1064131003.USD","161726","688331","BK0239","399441","LU2148510915.USD"],"gpt_icon":0},{"id":"2469057921","title":"荣昌生物(688331)9月23日主力资金净买入32.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469057921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469057921?lang=zh_cn&edition=full","pubTime":"2024-09-24 08:25","pubTimestamp":1727137557,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月23日收盘,荣昌生物报收于22.59元,下跌1.57%,换手率1.97%,成交量3.19万手,成交额7364.18万元。近5日资金流向一览见下表:荣昌生物融资融券信息显示,融资方面,当日融资买入227.82万元,融资偿还234.78万元,融资净偿还6.96万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400006187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","LU1064130708.USD","BK1583","LU2328871848.SGD","LU1064131003.USD","BK1574","688331","09995","LU2148510915.USD","BK0239","BK1161"],"gpt_icon":0},{"id":"2469136992","title":"荣昌生物(09995)上涨5.22%,报11.28元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2469136992","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469136992?lang=zh_cn&edition=full","pubTime":"2024-09-23 09:48","pubTimestamp":1727056117,"startTime":"0","endTime":"0","summary":"9月23日,荣昌生物(09995)盘中上涨5.22%,截至09:48,报11.28元/股,成交929.38万元。荣昌生物制药(烟台)股份有限公司的主营业务是发现、开发、生产和商业化同类首创、同类最佳的生物药物,主要针对自身免疫、肿瘤、眼科等重大疾病领域。公司在中国和美国设有实验研究机构和办事处,已创制出一批具有重大临床价值的生物新药。截至2024年中报,荣昌生物营业总收入7.4亿元、净利润-7.8亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/23094843411451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09995","LU1064131003.USD","BK0239","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","BK1161","BK1583","688331","LU2328871848.SGD","BK1574"],"gpt_icon":0},{"id":"2469618686","title":"荣昌生物几乎烧光IPO融资 累计亏逾30亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2469618686","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469618686?lang=zh_cn&edition=full","pubTime":"2024-09-23 05:45","pubTimestamp":1727041534,"startTime":"0","endTime":"0","summary":"日前,有媒体报道称, 荣昌生物 的大幅裁员涉及研发、生产多个部门,且裁员仍在继续。荣昌生物否认了裁员传言,回应表示“是基于公司战略发展需要的人员调整”。荣昌生物上市至今净利润累计亏损逾30亿元,营运资金主要依赖外部融资,今年以来,公司多次被传现金流紧张。荣昌生物两地上市累计融资逾60亿元,而连年亏损与高额研发支出几乎“烧光”了融资。截至二季度末,荣昌生物的现金规模为6.76亿元,是上市以来同期最低值,且A股IPO募集金额只剩下6000万元左右,而公司年均研发支出超过10亿元,营运资金捉襟见肘。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409230600569575ef62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409230600569575ef62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","BK1574","LU1969619763.USD","BK1583","688331","09995","BK1161"],"gpt_icon":0},{"id":"2468618986","title":"9月20日荣昌生物跌5.90%,易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468618986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468618986?lang=zh_cn&edition=full","pubTime":"2024-09-20 16:16","pubTimestamp":1726820191,"startTime":"0","endTime":"0","summary":"证券之星消息,9月20日荣昌生物跌5.90%创60日新低,收盘报22.95元,换手率2.42%,成交量3.92万手,成交额9081.42万元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共26家,其中持有数量最多的公募基金为易方达医疗保健行业混合A。易方达医疗保健行业混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000022533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","BK1583","LU2328871848.SGD","LU1064131003.USD","BK1574","09995","LU1969619763.USD","LU2148510915.USD","LU1064130708.USD","688331"],"gpt_icon":0},{"id":"2468602386","title":"港股异动 | 荣昌生物(09995)跌超5% 被传裁员上千人 公司指人员调整旨在优化经营团队结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2468602386","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468602386?lang=zh_cn&edition=full","pubTime":"2024-09-20 13:36","pubTimestamp":1726810613,"startTime":"0","endTime":"0","summary":"消息面上,近日,网络有传言称荣昌生物正在实施减员上千名计划,且接下来还将进一步加大调整力度。对此,有报道引述荣昌生物回应指,公司近期的人员调整非大幅裁员,是基于公司战略发展的需要,旨在优化经营团队结构,提升团队的专业能力和整体效率,实现团队的动态平衡,以更好地适应市场变化和业务需求。截至2024上半年,荣昌生物账上还剩6.73亿元,同比减少近四成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064130708.USD","LU2148510915.USD","BK0239","BK1161","09995","LU1064131003.USD","LU2328871848.SGD","LU1969619763.USD","BK1574","BK1583","688331"],"gpt_icon":0},{"id":"2468364660","title":"荣昌生物(09995)下跌5.05%,报10.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468364660","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468364660?lang=zh_cn&edition=full","pubTime":"2024-09-20 13:23","pubTimestamp":1726809831,"startTime":"0","endTime":"0","summary":"9月20日,荣昌生物(09995)盘中下跌5.05%,截至13:23,报10.9元/股,成交2007.38万元。荣昌生物制药(烟台)股份有限公司的主营业务是发现、开发、生产和商业化同类首创、同类最佳的生物药物,主要针对自身免疫、肿瘤、眼科等重大疾病领域。公司在中国和美国设有实验研究机构和办事处,已创制出一批具有重大临床价值的生物新药。截至2024年中报,荣昌生物营业总收入7.4亿元、净利润-7.8亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/20132343373337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1064130708.USD","BK1574","LU1064131003.USD","688331","BK0239","09995","BK1161","LU2148510915.USD","LU2328871848.SGD","BK1583","LU1969619763.USD"],"gpt_icon":0},{"id":"2468121667","title":"【港股通】荣昌生物(09995)跌超4.5% 据报回应裁员传闻:近期人员调整非大幅裁员","url":"https://stock-news.laohu8.com/highlight/detail?id=2468121667","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468121667?lang=zh_cn&edition=full","pubTime":"2024-09-20 13:22","pubTimestamp":1726809758,"startTime":"0","endTime":"0","summary":"金吾财讯 | 荣昌生物(09995)股价受压,午后跌幅扩大,截至发稿,报10.96港元,跌4.53%,成交额1926.51万港元。消息面上,对于近日市传荣昌生物裁员,媒体引述荣昌生物回应指出,公司近期的人员调整非大幅裁员,是基于其战略发展的需要,旨在优化经营团队结构,提升团队的专业能力和整体效率,实现团队的动态平衡,以更好地适应市场变化和业务需求。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200908/ZDU2M2ViYzhjNGM0OGI0Yjc0M2IyM2I2YWYxMTE5OTk0MjE4MDAxMQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/ZDU2M2ViYzhjNGM0OGI0Yjc0M2IyM2I2YWYxMTE5OTk0MjE4MDAxMQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1944571","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1161","BK1583","LU2328871848.SGD","LU1064131003.USD","BK1574","HSTECH","09995","LU1969619763.USD","LU2148510915.USD","LU1064130708.USD","HSCEI","688331","YANG"],"gpt_icon":0},{"id":"2468657283","title":"A股创新药概念震荡走低,海南海药跌超7%,睿智医药跌超5%;百奥泰、荣昌生物、恒瑞医药、广生堂等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2468657283","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468657283?lang=zh_cn&edition=full","pubTime":"2024-09-20 10:25","pubTimestamp":1726799158,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","300436","399300","BK0028","BK1583","LU0405327494.USD","BK0188","BK0077","BK0216","LU2488822045.USD","BK0239","BK1574","BK0060","BK0146","06978","LU2328871848.SGD","BK1161","600276","688177","000566","159992","BK0070","688331","LU1064131003.USD","BK0183","300149","LU1064130708.USD","LU0405327148.USD","LU1328615791.USD","09995","LU2148510915.USD","BK0196","LU1969619763.USD","BK0012"],"gpt_icon":0},{"id":"2468529613","title":"荣昌生物称近期人员调整非大幅裁员 旨在优化经营团队结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2468529613","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468529613?lang=zh_cn&edition=full","pubTime":"2024-09-19 17:44","pubTimestamp":1726739080,"startTime":"0","endTime":"0","summary":"针对“网上关于公司大幅度裁员的消息是否属实”这一问题,近期,荣昌生物在参加2024年半年度科创板制药及生物制品专场集体业绩说明会时表示,公司近期的人员调整非大幅裁员,是基于公司战略发展的需要,旨在优化经营团队结构,提升团队的专业能力和整体效率,实现团队的动态平衡,以更好地适应市场变化和业务需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919175953956f4a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919175953956f4a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","LU1064131003.USD","688331","LU2148510915.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2468383546","title":"荣昌生物(09995.HK):近期人员调整非大幅裁员 旨在优化经营团队结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2468383546","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468383546?lang=zh_cn&edition=full","pubTime":"2024-09-19 15:10","pubTimestamp":1726729800,"startTime":"0","endTime":"0","summary":"对于近日市传荣昌生物(09995.HK) 裁员,内媒引述荣昌生物回应指出,公司近期的人员调整非大幅裁员,是基于其战略发展的需要,旨在优化经营团队结构,提升团队的专业能力和整体效率,实现团队的动态平衡,以更好地适应市场变化和业务需求。荣昌生物现报11.88元,升1.89%,成交243.45万股,涉资2,932.29万元。(jl/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-09-19 12:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1382340/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","LU1969619763.USD","LU1064130708.USD","LU2328871848.SGD","LU1064131003.USD","09995","BK1583","LU2148510915.USD","BK0239","BK1574","688331"],"gpt_icon":0},{"id":"2468543813","title":"荣昌生物:近期人员调整非大幅裁员 系“实现团队的动态平衡”","url":"https://stock-news.laohu8.com/highlight/detail?id=2468543813","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468543813?lang=zh_cn&edition=full","pubTime":"2024-09-19 14:40","pubTimestamp":1726728014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2328871848.SGD","LU1969619763.USD","BK4231","ADC","BK1161","BK1574","688331","LU1064131003.USD","09995","LU1064130708.USD","LU2148510915.USD","BK0239","BK1583","BK4080"],"gpt_icon":0},{"id":"2468567474","title":"荣昌生物(688331)9月18日主力资金净卖出1091.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468567474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468567474?lang=zh_cn&edition=full","pubTime":"2024-09-19 08:19","pubTimestamp":1726705194,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月18日收盘,荣昌生物报收于24.27元,下跌4.82%,换手率1.82%,成交量2.95万手,成交额7224.25万元。9月18日的资金流向数据方面,主力资金净流出1091.41万元,占总成交额15.11%,游资资金净流入1086.79万元,占总成交额15.04%,散户资金净流入4.62万元,占总成交额0.06%。近5日资金流向一览见下表:荣昌生物融资融券信息显示,融资方面,当日融资买入220.05万元,融资偿还392.06万元,融资净偿还172.01万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091900005094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1064131003.USD","09995","LU2328871848.SGD","LU2148510915.USD","688331","LU1969619763.USD","BK1161","BK1574","BK1583","LU1064130708.USD"],"gpt_icon":0},{"id":"2468342822","title":"荣昌生物大跌5.02% 3家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2468342822","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468342822?lang=zh_cn&edition=full","pubTime":"2024-09-18 10:46","pubTimestamp":1726627560,"startTime":"0","endTime":"0","summary":"09月18日,荣昌生物股价大幅下跌,截至10点46分,荣昌生物下跌5.02%,报24.22元/股,成交4070万元,换手率1.02%。此外,数据统计显示,近半年内3家券商给予增持建议,14家券商给予买入建议,2家券商给予中性建议。资金动向截止发稿,荣昌生物获得主力净流出653万元,其中超大单流出352万元,大单流出300万元。最新财报显示,今年中报,荣昌生物实现营业收入7.42亿元,同比增长75.59%,净利润为-7.80亿元,同比减少10.96%,基本每股收益为-1.45元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918104609ab643feb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918104609ab643feb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688331","LU1064131003.USD","LU1064130708.USD","LU2148510915.USD"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-31","address":"山东省烟台市福山区中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号","stockEarnings":[{"period":"1week","weight":0.5542},{"period":"1month","weight":0.3699},{"period":"3month","weight":-0.1698},{"period":"6month","weight":-0.3372},{"period":"1year","weight":-0.4294},{"period":"ytd","weight":-0.4343}],"companyName":"荣昌生物制药(烟台)股份有限公司","boardCode":"AI0027","perCapita":"31185股","boardName":"医药制造业","registeredCapital":"54433万元","compareEarnings":[{"period":"1week","weight":0.2138},{"period":"1month","weight":0.1739},{"period":"3month","weight":0.1133},{"period":"6month","weight":0.0871},{"period":"1year","weight":0.0727},{"period":"ytd","weight":0.1215}],"survey":" 荣昌生物制药(烟台)股份有限公司是一家具有全球化视野的创新型生物制药企业,自成立以来一直专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。公司主营业务是发现、开发与商业化创新、有特色的同类首创(first-in-class)与同类最佳(best-in-class)生物药,以创造药物临床价值为导向,为自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域提供安全、有效、可及的临床解决方案,以满足大量尚未被满足的临床需求。公司的核心产品为泰它西普、维迪西妥单抗、RC28。","serverTime":1727872385408,"listedPrice":48,"stockholders":"5193人(较上一季度减少3.78%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(688331)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(688331)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,688331,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(688331)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(688331)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}